发明名称 HEPATITIS C INHIBITOR PEPTIDES
摘要 Formula (I) wherein a is 0 or 1; b is 0 or 1; Y is H or C1-6 alkyl; B is H, an acyl derivative or a sulfonyl derivative; W is hydroxy or a N-substituted amino; or a pharmaceutically acceptable salt or ester thereof, for use in th e treatment of hepatitis C virus (HCV) infection.
申请公布号 CA2336597(A1) 申请公布日期 2000.02.24
申请号 CA19992336597 申请日期 1999.08.09
申请人 BOEHRINGER INGELHEIM (CANADA) LTD. 发明人 GOUDREAU, NATHALIE;GHIRO, ELISE;POUPART, MARC-ANDRE;TSANTRIZOS, YOULA S.;RANCOURT, JEAN;CAMERON, DALE;BAILEY, MURRAY D.;LLINAS-BRUNET, MONTSE
分类号 C12N15/09;A61K31/13;A61K31/7052;A61K38/00;A61K38/21;A61K38/55;A61K45/00;A61P1/16;A61P31/12;A61P31/14;A61P43/00;C07K1/10;C07K5/10;C07K5/107;C07K7/06;C07K14/81;(IPC1-7):C07K14/81 主分类号 C12N15/09
代理机构 代理人
主权项
地址